Paju, South Korea

Bumkyu Choi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National Cancer Center, Protanbio Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bumkyu Choi. Retrieved from https://idiyas.com/inventor/bumkyu-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bumkyu Choi: Innovator in Cancer Therapy

Introduction

Bumkyu Choi is a notable inventor based in Paju, South Korea. He has made significant contributions to the field of cancer therapy through his innovative work. His research focuses on developing advanced treatments that target specific cancer cells.

Latest Patents

Bumkyu Choi holds a patent for a chimeric antigen receptor targeting BCMA and its use. This patent represents a crucial advancement in the treatment of certain types of cancers, particularly those affecting the immune system. He has 1 patent to his name, showcasing his commitment to innovation in medical technology.

Career Highlights

Throughout his career, Bumkyu Choi has worked with esteemed organizations such as the National Cancer Center and Protanbio Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Bumkyu Choi has collaborated with notable colleagues, including Sangjin Lee and Hyeonseok Eom. These partnerships have enhanced his research and development efforts, leading to significant advancements in cancer treatment.

Conclusion

Bumkyu Choi's work exemplifies the spirit of innovation in the medical field. His contributions to cancer therapy through his patent and collaborations highlight the importance of research in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…